1. Home
  2. GOCO vs ALLR Comparison

GOCO vs ALLR Comparison

Compare GOCO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.14

Market Cap

17.7M

Sector

Finance

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.38

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOCO
ALLR
Founded
2001
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
19.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GOCO
ALLR
Price
$1.14
$1.38
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.75
$9.75
AVG Volume (30 Days)
53.5K
120.8K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$361,845,000.00
$320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$77.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.77
52 Week High
$10.56
$2.35

Technical Indicators

Market Signals
Indicator
GOCO
ALLR
Relative Strength Index (RSI) 41.27 63.51
Support Level $1.00 $1.00
Resistance Level $1.35 $1.42
Average True Range (ATR) 0.10 0.08
MACD 0.02 0.01
Stochastic Oscillator 49.28 76.70

Price Performance

Historical Comparison
GOCO
ALLR

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions, so it can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. The proprietary technology platform integrates artificial intelligence and modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: